The Melatonin Dosage Problem: Why More Isn't Better

What Your Body Actually Produces

Your pineal gland naturally produces melatonin in response to darkness. This endogenous production follows a circadian rhythm — levels begin to rise in the evening, peak between 2:00 and 4:00 AM, and decline toward morning. The total amount your body produces each night is relatively small. Research published by Brzezinski (1997) in the New England Journal of Medicine estimated that peak nocturnal melatonin levels in healthy adults correspond to roughly 0.1 to 0.3mg in circulation.

This means a standard 5mg melatonin supplement delivers approximately 15 to 50 times the amount your body would naturally produce at peak output. A 10mg tablet delivers 30 to 100 times. These are supraphysiological doses by any measure — yet they're marketed as a gentle, natural sleep aid.

The MIT Research: 0.3mg Is the Sweet Spot

In 2001, Zhdanova et al. at MIT published a study in Clinical Pharmacology & Therapeutics that fundamentally challenged conventional melatonin dosing. The researchers compared doses of 0.3mg and 3.0mg in older adults with insomnia. The 0.3mg dose — ten times lower than the most common OTC option — restored nighttime melatonin levels to their natural physiological range and improved sleep quality without residual effects.

The 3.0mg dose also improved sleep onset but caused plasma melatonin levels to remain elevated well into the next day. This supraphysiological elevation was associated with next-day grogginess and a disruption of the natural melatonin rhythm. Dr. Richard Wurtman, the MIT neuroscientist who holds the original patent on melatonin as a sleep aid, has stated publicly that the doses available commercially are far higher than what the research supports.

Supraphysiological Dosing: The Side Effects

Taking melatonin at doses well above what your body naturally produces doesn't just fail to help — it may actively cause problems. Research has identified several concerns with high-dose melatonin use.

Next-day grogginess. Supraphysiological doses can elevate melatonin levels well into the morning hours, leaving users feeling drowsy, foggy, and sluggish. This "melatonin hangover" is one of the most commonly reported complaints and is a direct consequence of doses that overwhelm the body's natural clearance mechanisms.

Tolerance buildup. Costello et al. (2014) published findings suggesting that chronic use of exogenous melatonin at high doses may downregulate melatonin receptors (MT1 and MT2) in the brain. Over time, this receptor desensitization may reduce your body's natural sensitivity to melatonin — meaning you need more to achieve the same effect, creating a cycle of escalating doses.

Disrupted circadian signaling. Melatonin is not just a sleep molecule — it's a timing signal. It tells your body when it's night. When you flood your system with supraphysiological doses, you distort this signal. Lewy et al. (2006) published research in Chronobiology International demonstrating that melatonin's circadian effects are dose-dependent, and that excessive doses can actually shift circadian timing in unintended ways.

Hormonal interactions. Melatonin interacts with the hypothalamic-pituitary axis and may influence reproductive hormones at high doses. Voordouw et al. (1992) published a study in the Journal of Clinical Endocrinology & Metabolism showing that 300mg doses of melatonin suppressed LH levels in women. While typical supplement doses are far lower, the principle that melatonin has hormonal effects beyond sleep is well established.

Why People Keep Taking Too Much

The melatonin overdosing problem persists for a simple reason: when a 3mg tablet doesn't seem to work, people take two. When 6mg stops working, they try 10mg. This escalation pattern is a predictable consequence of starting at a dose that's already too high. The initial supraphysiological dose may cause receptor downregulation, which reduces effectiveness, which prompts dose increases, which causes further downregulation.

Grigg-Damberger and Ianakieva (2017) published a review in the Journal of Clinical Sleep Medicine noting that melatonin is the most commonly used sleep aid in the United States, with usage rates increasing significantly year over year — yet sleep complaints are not decreasing. The authors argued for more physician-guided dosing rather than the self-directed, more-is-better approach that dominates consumer behavior.

Food-Sourced Melatonin: A Different Approach

Tart cherries — specifically Montmorency cherries — are one of the few food sources that naturally contain melatonin. Howatson et al. (2012) published a study in the European Journal of Nutrition showing that tart cherry juice consumption increased urinary melatonin metabolites (6-sulfatoxymelatonin) and was associated with improvements in sleep duration and quality in healthy adults.

The melatonin content in tart cherries is measured in micrograms, not milligrams. This means the amounts delivered are far closer to the physiological range that the MIT research identified as optimal. Pigeon et al. (2010) published findings in the Journal of Medicinal Food showing that tart cherry juice may support sleep quality in older adults with insomnia, with the authors attributing the effect to the naturally occurring melatonin and other phytonutrients working together.

This is a fundamentally different approach than taking a 5mg melatonin tablet. Food-sourced melatonin from tart cherry delivers trace amounts in a matrix of anthocyanins, polyphenols, and other compounds that research suggests may work synergistically. Rather than overwhelming your melatonin receptors with a supraphysiological dose, tart cherry provides a gentle nudge that may complement your body's natural production.

Beyond Melatonin: Supporting Sleep Through Multiple Pathways

One of the limitations of isolated melatonin supplementation is that it addresses only one mechanism of sleep — circadian timing. But sleep quality depends on multiple factors: nervous system relaxation, muscle tension release, stress hormone regulation, and neurotransmitter balance.

This is why CHRY's formula takes a multi-pathway approach. Tart cherry (500mg) provides food-sourced melatonin in physiological amounts. Magnesium glycinate (300mg) may support muscle relaxation and nervous system calming through GABA receptor modulation. L-theanine (200mg) promotes alpha brain wave activity associated with calm wakefulness and the transition to sleep. Apigenin from chamomile (50mg) acts as a mild GABA-A receptor agonist. Together, these ingredients address sleep from multiple angles rather than relying on a single molecule at an excessive dose.

The Bottom Line

The melatonin dosage problem is a case study in how supplement culture can go wrong. More is not better. The research from MIT and elsewhere consistently points to the same conclusion: physiological doses of melatonin (around 0.3mg) may be more effective and better tolerated than the 3-10mg doses that dominate the market.

CHRY takes a different approach entirely. Rather than delivering isolated, supraphysiological melatonin, it provides food-sourced melatonin from tart cherry in naturally occurring trace amounts — paired with complementary ingredients that may support sleep and recovery through multiple pathways. It's an approach grounded in how your body actually works, not in the assumption that more milligrams means better sleep.